Trademark: 79146229
Status Date
Friday, May 28, 2021
Registration Number
4634961
Registration Date
Tuesday, November 11, 2014
Filing Date
Thursday, February 20, 2014
Published for Opposition
Tuesday, August 26, 2014
Cancellation Date
Friday, May 28, 2021
5 Pharmaceutical preparations for treatment of autoimmune diseases; pharmaceutical preparations comprising an anti-tumor necrosis factor (TNF) alpha monoclonal antibody
The wording "ADALMEA" has no meaning in a foreign language.
Apr 30, 2023
Total Invalidation Processed By The Ib
Apr 1, 2023
Generic Madrid Transaction Sent To Ib
Apr 1, 2023
Generic Madrid Transaction Created
Jan 28, 2022
Total Invalidation Of Reg Ext Protection Created
May 28, 2021
Cancelled Section 71
Apr 24, 2015
Final Decision Transaction Processed By Ib
Apr 9, 2015
Final Disposition Notice Sent To Ib
Apr 9, 2015
Final Disposition Processed
Feb 11, 2015
Final Disposition Notice Created, To Be Sent To Ib
Nov 11, 2014
Registered-Principal Register
Aug 26, 2014
Published For Opposition
Aug 22, 2014
Notification Processed By Ib
Aug 6, 2014
Notification Of Possible Opposition Sent To Ib
Aug 6, 2014
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 6, 2014
Notice Of Publication
Jul 22, 2014
Law Office Publication Review Completed
Jul 12, 2014
Approved For Pub - Principal Register
Jul 8, 2014
Teas/Email Correspondence Entered
Jul 8, 2014
Correspondence Received In Law Office
Jun 27, 2014
Assigned To Lie
Jun 20, 2014
Refusal Processed By Ib
Jun 18, 2014
Teas Response To Office Action Received
Jun 2, 2014
Non-Final Action Mailed - Refusal Sent To Ib
Jun 2, 2014
Refusal Processed By Mpu
Jun 1, 2014
Non-Final Action (Ib Refusal) Prepared For Review
May 31, 2014
Non-Final Action Written
May 28, 2014
Assigned To Examiner
May 10, 2014
Application Filing Receipt Mailed
May 6, 2014
New Application Office Supplied Data Entered
May 5, 2014
Limitation From Original Application Entered
May 1, 2014
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
